Zeitschriftenaufsatz | 2014 Open Access

Inhibition of STAT5: a therapeutic option in BCR-ABL1-driven leukemia.

Autor:in

Berger, Angelika; Sexl, Veronika; Valent, Peter; Moriggl, Richard;

Publikationen als Autor:in / Herausgeber:in der Vetmeduni

Sexl, Veronika

Journal

OncoTarget

Schlagwörter

Animals; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy*; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism; Molecular Targeted Therapy; STAT5 Transcription Factor/antagonists & inhibitors*; STAT5 Transcription Factor/metabolism;

Dokumententyp

Originalarbeit

CC Lizenz

CCBY

Open Access Type

Gold

ISSN/eISSN

1949-2553 -

DOI

10.18632/oncotarget.2465

PubMed ID

25333255

Projekt

Jak Stat - Signalling from Basis to Disease